KENALOG Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kenalog, and when can generic versions of Kenalog launch?
Kenalog is a drug marketed by Delcor Asset Corp, Sun Pharm Inds Inc, and Apothecon. and is included in nine NDAs.
The generic ingredient in KENALOG is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kenalog
A generic version of KENALOG was approved as triamcinolone acetonide by TARO on October 1st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KENALOG?
- What are the global sales for KENALOG?
- What is Average Wholesale Price for KENALOG?
Summary for KENALOG
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 78 |
Patent Applications: | 4,321 |
Drug Prices: | Drug price information for KENALOG |
What excipients (inactive ingredients) are in KENALOG? | KENALOG excipients list |
DailyMed Link: | KENALOG at DailyMed |
Recent Clinical Trials for KENALOG
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Florida Orthopaedic Institute | Phase 1 |
Foundation for Orthopaedic Research and Education | Phase 1 |
Next Generation Regenerative Medicine LLC | Phase 1/Phase 2 |
Pharmacology for KENALOG
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for KENALOG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delcor Asset Corp | KENALOG | triamcinolone acetonide | CREAM;TOPICAL | 083943-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sun Pharm Inds Inc | KENALOG | triamcinolone acetonide | SPRAY;TOPICAL | 012104-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | KENALOG | triamcinolone acetonide | LOTION;TOPICAL | 084343-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | KENALOG-H | triamcinolone acetonide | CREAM;TOPICAL | 086240-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | KENALOG IN ORABASE | triamcinolone acetonide | PASTE;DENTAL | 012097-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | KENALOG | triamcinolone acetonide | LOTION;TOPICAL | 084343-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |